1. Effects of 2-year vitamin B12 and folic acid supplementation in hyperhomocysteinemic elderly on arterial stiffness and cardiovascular outcomes within the B-PROOF trial
- Author
-
de Groot Lc, Mattace Raso Fu, de Jongh Rt, van der Zwaluw Nl, Johanna M. Geleijnse, van Dijk Sc, Anke W. Enneman, van Wijngaarden Jp, Henk J. Blom, van den Meiracker Ah, Edith J. M. Feskens, Yvo M. Smulders, Elske M. Brouwer-Brolsma, van Schoor Nm, Annelies C. Ham, André G. Uitterlinden, Rosalie A. M. Dhonukshe-Rutten, van der Velde N, Paul Lips, Karin M. A. Swart, Internal Medicine, Epidemiology, EMGO+ - Lifestyle, Overweight and Diabetes, Epidemiology and Data Science, Clinical chemistry, Internal medicine, ICaR - Circulation and metabolism, EMGO - Lifestyle, overweight and diabetes, Amsterdam Public Health, Amsterdam Movement Sciences, and Geriatrics
- Subjects
Male ,Homocysteine ,Nutrition and Disease ,Cerebrovascular disorders ,Physiology ,Blood Pressure ,Carotid Intima-Media Thickness ,law.invention ,chemistry.chemical_compound ,Randomized controlled trial ,law ,Risk Factors ,Voeding en Ziekte ,Medicine ,Pulse wave velocity ,Trials ,Aged, 80 and over ,Cardiovascular disease ,Arterial stiffness ,Vitamin B 12 ,Treatment Outcome ,Cardiovascular Diseases ,Cardiology ,cardiovascular system ,Female ,Cardiology and Cardiovascular Medicine ,medicine.medical_specialty ,Hyperhomocysteinemia ,Pulse Wave Analysis ,Placebo ,Folic Acid ,Vascular Stiffness ,SDG 3 - Good Health and Well-being ,Double-Blind Method ,Internal medicine ,Internal Medicine ,Humans ,Vitamin B12 ,cardiovascular diseases ,VLAG ,Nutrition ,Aged ,Global Nutrition ,Wereldvoeding ,business.industry ,medicine.disease ,Atherosclerosis ,Surgery ,Blood pressure ,chemistry ,Dietary Supplements ,business - Abstract
Introduction: Hyperhomocysteinemia is an important cardiovascular risk indicator in the oldest old, and is associated with elevated arterial stiffness in this age group. Since several intervention trials reported a lack of benefit of B-vitamin supplementation on cardiovascular outcomes, we aimed to investigate the effect of B-vitamin supplementation on arterial stiffness and atherosclerosis in hyperhomocysteinemic elderly patients. Methods: The B-PROOF study is a double-blind, randomized controlled trial, including 2919 elderly aged at least 65 years, with hyperhomocysteinemia (12-50 [mu]mol/l), treated with B-vitamins (500 [mu]g vitamin B12 and 400 [mu]g folic acid) or placebo for 2 years. In a subgroup (n = 569), the effect of B-vitamins on pulse wave velocity (PWV) was investigated as a measurement of arterial stiffness. To measure atherosclerosis, carotid intima-media thickness (IMT) measures had been used. Incidents of cardiovascular and cerebrovascular events were determined via structured questionnaires, and blood pressure was also measured. Results: Compared to placebo, B-vitamin supplementation lowered serum homocysteine by 3.6 [mu]mol/l (P
- Published
- 2015